SEOUL, Aug. 23 (Korea Bizwire) — SK bioscience Co., a pharmaceutical affiliate under South Korea’s SK Group, said Wednesday it will produce 5 million doses of its signature cell-based influenza vaccine SKYCellflu nationwide from next month for the coming winter season. It resumed the production two years after it had stopped manufacturing the prefilled syringe-typed [...]
SEOUL, Nov. 7 (Korea Bizwire) — The number of South Koreans who died this fall after getting seasonal flu shots has risen close to 100, health authorities said Saturday, though any correlation has not been confirmed between nearly 99 percent of the fatalities and the flu vaccinations. The Korea Disease Control and Prevention Agency (KDCA) [...]
SEOUL, Oct. 31 (Korea Bizwire) — South Korea’s public health agency said Saturday that a total of 83 people, most of whom are elderly, died after being administered with a seasonal flu vaccine. The deaths have stoked public anxiety over the safety of flu vaccines, but the Korea Disease Control and Prevention Agency (KDCA) said [...]
SEOUL, Sept. 23 (Korea Bizwire) — Health experts on Wednesday warned of a potential so-called twindemic during winter, and the mishandling of flu vaccines here may exacerbate the coronavirus situation. The country’s virus fight has been widely expected to face hurdles as the winter season approaches, as respiratory viruses, including influenza and COVID-19, have nearly [...]
SEOUL, July 22 (Korea Bizwire) – Despite the blazing hot weather, pharmaceutical companies are gearing up to compete in the market for flu vaccines for the winter season, particularly tetravalent flu vaccines that are expected to hit the market this year. Tetravalent flu vaccines, which mark the next development step after trivalent flu vaccines, provide protection against [...]